Oncogene alterations in non-small cell lung cancer with <i>FGFR1</i> amplification-novel approach to stratify patients who benefit from FGFR inhibitors.

Kitai, Hidenori; Ebi, Hiromichi

Oncogene alterations in non-small cell lung cancer with FGFR1 amplification-novel approach to stratify patients who benefit from FGFR inhibitors.

Kitai, Hidenori; Ebi, Hiromichi.

Affiliation

Kitai H; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.

Transl Lung Cancer Res ; 13(3): 684-688, 2024 Mar 29.

Article in En | MEDLINE | ID: mdl-38601453

Key words

FGFR inhibitor; Fibroblast growth factor receptor 1 (FGFR1); biomarker; squamous cell lung cancer (SQCLC)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2024 Document type: Article Affiliation country: Japón

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2024 Document type: Article Affiliation country: Japón